Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples